Consistent with previously published articles in our study, patients with higher levels of NT-proBNP and higher death likelihoods were at a higher risk of HTN, CAD, diabetes mellitus, kidney disease and had higher levels of BUN creatinine, leucocytes, and PCT. This evidence concerns the gene NPPB and hypertensive disorder.